AI app aims to boost nutrition and survival in pancreatic cancer patients

NCT ID NCT07167264

Recruiting now Knowledge-focused Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study is testing whether an AI-powered mobile app can help assess and improve nutrition in 200 patients who have had surgery for pancreatic cancer. The app collects data on symptoms like pain, appetite, and weight, and uses artificial intelligence to guide follow-up care. The goal is to see if this approach can improve patients' recovery and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AI-powered mobile app for nutritional assessment and follow-up
What this could lead to: If successful, this could provide a simple, AI-driven tool to better manage nutrition and follow-up care for pancreatic cancer survivors, potentially improving their quality of life and survival.
What could go wrong: This is an early feasibility study with no control group, so results may not prove the app directly improves outcomes. The AI model may not work well for all patients, and the study is small.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

malignant pancreatic neoplasm pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PANCREATIC CANCER

Contacts and locations

Locations

Shanghai General Hospital
RECRUITING

Shanghai, Shanghai Municipality, 200080, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.